RISK FACTORS FOR THROMBOSIS AND PRIMARY THROMBOSIS PREVENTION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS WITH OR WITHOUT ANTIPHOSPHOLIPID ANTIBODIES
Nermeen Ahmed Foad;
Abstract
Antiphospholipid antibodies (aPL), namely anticardiolipin antibodies (aCL) and lupus anticoagulant (LAC), have been associated with an increased risk of thrombosis in systemic lupus erythematosus (SLE).
We examined additional thrombosis risk factors (aP
We examined additional thrombosis risk factors (aP
Other data
| Title | RISK FACTORS FOR THROMBOSIS AND PRIMARY THROMBOSIS PREVENTION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS WITH OR WITHOUT ANTIPHOSPHOLIPID ANTIBODIES | Other Titles | عوامل الخطورة لحدوث التخثر والوقاية الأولية منه في مرضى الذئبة الحمراء إيجابي و سلبي مضادات الدهون الفسفورية | Authors | Nermeen Ahmed Foad | Keywords | RISK FACTORS FOR THROMBOSIS AND PRIMARY THROMBOSIS PREVENTION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS WITH OR WITHOUT ANTIPHOSPHOLIPID ANTIBODIES | Issue Date | 2010 | Description | Antiphospholipid antibodies (aPL), namely anticardiolipin antibodies (aCL) and lupus anticoagulant (LAC), have been associated with an increased risk of thrombosis in systemic lupus erythematosus (SLE). We examined additional thrombosis risk factors (aP |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 100238r3731.pdf | 173.33 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.